|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Alveolar epithelial type II cells (AET2) respond with exocytosis of surfactant containing lamellar bodies to stimulation with mechanical stretch and secretagogues, a process that is fundamental for maintaining alveolar stability and lung gas exchange. In the present study in cultured rat AET2, we employed botulinum C2 toxin, a binary toxin which ADP ribosylates nonmuscle G-actin, as a specific tool
to probe the role of the actin microfilament system in the surfactant secretory process. Incubation of
AET2 with C2 toxin caused a dose-dependent decay of the cellular F-actin content to a minimum of
20% of baseline, concomitant with an increase in monomeric actin. In parallel, a significant augmentation of baseline surfactant secretion up to twofold elevated levels above control was noted, as assessed by the release of prelabeled phosphatidylcholine. Pretreatment with phalloidin, which stabilized F-actin and reduced the level of G-actin, prevented the C2 toxin-elicited enhancement of
baseline surfactant secretion. Even low C2 toxin concentrations, resulting in a reduction of total cellular F-actin content of
10%, sufficed to augment secretagogue (ATP) and, more impressively, mechanical stress elicited an increase in surfactant secretion; the response to the biophysical challenge
more than doubled. When investigated in the absence of toxin, different secretagogues (ATP, phorbol ester, betamimetics) caused a rapid-onset, transient reduction of F-actin in the range between 15 and 25% as a consistent part of their secretory response pattern. These data suggest that the state of
actin polymerization is intimately linked to the exocytosis process underlying surfactant secretion in
AET2. Microfilament system-related compartmentalization effects and/or or the impact of the state of
actin assembly on signaling events may be considered as underlying events.
| |
INTRODUCTION |
|---|
|
|
|---|
Deep inflation of the lungs provokes stretching of the alveolar epithelial barrier and is regarded as the predominant physiologic stimulus for surfactant secretion in alveolar epithelial type II cells (AET2) (1, 2). In this distinct cell type, at the alveolar surface both lipid and protein surfactant components are stored in cytoplasmic organelles, the lamellar bodies, which are released by classic exocytosis. Translocation of the lamellar bodies to the apical epithelial membrane and fusion of the lamellar body and the plasma membrane are essential steps in the later stage of the secretory process. Cytoskeletal components and contractile proteins have been suggested as being part of mechanotransduction pathways (3, 4). Previous histologic examinations revealed the presence of actin beneath the cell surface in AET2 in close association with lamellar bodies (5, 6), and actin-binding proteins such as spectrins and annexins have been implicated in the surfactant secretory process (7). Experiments employing cytochalasins to probe the role of actin in the process of alveolar epithelial surfactant secretion did, however, give controversial results. Both a reduction of secretory events as well as an increase in the release of surfactant was noted (1, 8). Such inconsistencies may be related to the limited specificity of cytochalasins. These agents bind to different cellular target sites, resulting in a complex interaction with the microfilamentous network (9, 10) and they may effect a redistribution of actin rather than reducing the total quantity of filamentous actin (11).
A recently described specific tool for evaluating the impact of actin assembly on cell functions is botulinum C2 toxin, a binary toxin consisting of the components C2I and C2II. C2II promotes the translocation of C2I into eucaryotic cells, and C2I selectively ribosylates monomeric G-actin with adenosine diphosphate (ADP), which drastically reduces the actin polymerization rate (12). In previous histologic studies employing C2 toxin for investigating the role of filamentous actin in pulmonary cell function, we noted a critical role of this microfilament system for the maintenance of capillary endothelial barrier function as well as enhanced lamellar body membrane fusion and secretion in C2 toxin-treated lungs (13). Here we describe that C2 toxin treatment of purified rat AET2 results in marked amplification of surfactant secretion in parallel with the toxin-elicited F-actin decay and G-actin accumulation. In addition, the epithelial cells were noted to respond with rapid-onset, transient actin depolymerization as part of their secretory response to different stimuli. These data support a significant role of the actin microfilament system in the regulation of surfactant secretion in alveolar epithelial cells.
| |
METHODS |
|---|
|
|
|---|
Male CD-18 Sprague-Dawley rats (180-200 g) were purchased from Charles River (Sulzfeld, Main, Germany). Elastase (type EC 134; specific activity, 135 U/mg protein) was purchased from Elastin Products Company (St. Louis, MO). Dulbecco's modified Eagle's medium (DMEM) was obtained from Gibco (Karlsruhe, Germany). [3H]- methyl choline and [32P]nicotinamide-adenine dinucleotide (NAD) was from Amersham (Dreieich, Germany). Tissue culture plastic was purchased from Becton-Dickinson (Heidelberg, Germany). Silicone elastomer Silgard 184 was obtained from Dow Corning Corporation (Wiesbaden, Germany).
Isolation of AET2
AET2 were isolated as described in detail previously (1). Briefly, inflated and perfused lungs from specific pathogen-free male CD-18 Sprague-Dawley rats were lavaged and filled to total lung capacity with solution containing elastase (30 U/ml) and trypsin (0.05 mg/ml). Lungs were minced and free cells were separated from lung tissue by sequential filtration through sterile gauze and 100- and 10-µm nylon mesh. "Panning" of the resultant cell suspension was performed by rat immunoglobulin G-coated plates. Nonadherent type II cells were harvested after 1 h and resuspended in DMEM containing 10% fetal calf serum. The yield of type II epithelial cells from each rat was in the range of 30-50 × 106 cells. The percentage of type II cells was 95 ± 3% as assessed by modified Papanicolaou, tannic acid, and alkaline phosphatase staining. Contaminating cells included alveolar macrophages (< 4% in all experiments) and neutrophils (< 2%). AET2 viability, as assessed by 5-carboxyfluorescein diacetate (CFDA) loading and trypan blue exclusion, ranged persistently greater than 95%. Lactate dehydrogenase (LDH) release as one indicator of cellular damage ranged less than 2% of total enzyme activity as compared with the total release in response to the pore-forming agent mellitin (100 µg/ml).
Determination of Surfactant Secretion
Freshly isolated cells were seeded at a density of 5 × 105 cells per well
on 12-well culture dishes. The plating density was typically 8 × 104/cm2
(
64% plating efficiency). After pre-labeling with [3H]choline (1 µCi/
ml) for 18 h, the cells were washed and medium was replaced by unlabeled serum-free DMEM containing C2 toxin or secretagogues or
both. After incubation for preset time periods, medium was removed
and centrifuged to sediment possibly detached cells, which were not
regained and used in the assays. The monolayer was scraped off and
lipids from both medium and cells were extracted according to the
Folch partition (16). The amount of phosphatidylcholine (PC) secretion was calculated as the percentage of [3H]PC contained in the medium as related to the total amount of [3H]PC in cells plus medium.
To determine the effect of mechanical distension on surfactant secretion of type II cells, a stretching device as described by Wirtz and
Dobbs (1) was employed. Distension was achieved by applying hydrostatic pressure to the bottom of the plates (silicon membranes with an
area of 9.6 cm2), with an overall increase in area of 18-25%. Separate
control experiments with thin-layer chromatography ascertained that
the radioactive lipids secreted from both unstimulated and stimulated cells are 95 ± 2% PC (data not given in detail).
Measurement of G- and F-Actin
Cells were cultured on 35-mm dishes at a density of 3 × 106 cells per well (plating density was typically 4 × 105/cm2). Measurement of G-actin was performed in the supernatant of homogenized cells by employing a deoxyribonuclease (DNAse)-I inhibition assay as described (17). Briefly, cell lysates were co-incubated with defined amounts of DNAse and DNA (reaction assessed by absorbency at 260 nm), and the amount of G-actin was calculated from the DNAse inhibition by comparison with a standard curve. F-actin was measured by binding of rhodamine-phalloidin to actin filaments in permeabilized and formaldehyde-fixed type 2 cells as described (18), and the rhodamine content in the methanolic extract was determined with spectrofluorophotometry.
Polyacrylamide Gel Electrophoresis (PAGE) of [32P]ADP Ribolysated AET2 Protein
ADP ribosylation was performed essentially as described by Aktories and colleagues (19). AET2 were treated on culture dishes with different concentrations of C2 toxin for 2 h. The cells were transferred to test tubes, pelleted, and lysed by addition of hypotonic medium (5 mM EDTA, 10 mM triethanolamine). ADP ribosylation with C2 toxin component I was again performed on cell lysates in the presence of [32P]NAD for 1 h. The reaction was stopped by addition of trichloracetic acid and the labeled proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), according to the procedure of Lämmli (20). The gel was autoradiographed on Kodak X-Omat film with an exposure time of 2 d. Quantification was done by means of densitometric scanning at 550 nm using a thin-layer chromatography scanner II from Camag (Muttenz, Switzerland).
Statistical Analysis
For statistical comparison, one-way analysis of variance was performed. A level of p < 0.05 was considered to be significant.
| |
RESULTS |
|---|
|
|
|---|
Influence of C2 Toxin and Phalloidin on the G- and F-Actin Ratio
Actin represents approximately 20-25% of the AET2 total protein content with approximately equal contribution of both G- and F-actin (Table 1). Treatment of the epithelial cells with C2 toxin caused a dose-dependent progressive depletion of the cellular F-actin content to values ranging below 20% of baseline data (Figure 1). Concomitantly, the G-actin concentration progressively increased (Figure 2). In contrast, AET2 exposure to phalloidin, which is known to stabilize F-actin, resulted in a marked G-actin decay with nadir values of 38 ± 7% of baseline after 0.5 h (Figure 3).
|
|
|
|
Influence of C2 Toxin and Phalloidin on Surfactant Secretion in the Absence of Secretagogues
The C2 toxin-induced F-actin decay was paralleled by a dose-dependent augmentation of baseline epithelial surfactant secretion (Figure 4). At the maximum concentration of C2 toxin employed (375/750 ng/ml C2I/II), the diphosphatidyl-choline ([3H]- DPPC) release ranged approximately twofold over control values assessed in the absence of toxin. Phalloidin pretreatment did not affect the low baseline level of AET2 surfactant secretion (Figure 5); however, it blocked the augmentation of [3H]DPPC release provoked by a subsequent C2 toxin challenge.
|
|
Influence of C2 Toxin on Secretagogue and Stretch-induced Surfactant Secretion
As anticipated, AET2 incubation with adenosine triphosphate (ATP) provoked an augmentation of surfactant secretion to two- to threefold increased values over baseline level (Figure 6). When co-applied with concentrations of C2 toxin, which itself did not substantially enhance baseline [3H]PC release (125/ 250 ng/ml), the ATP-elicited secretory response was significantly increased. A corresponding, although even more prominent, effect of C2 toxin pretreatment was noted for stretch- induced surfactant secretion (Figure 7). Stretch alone caused an approximate doubling of baseline [3H]PC release. When applying such stress to epithelial cells pretreated with the per se ineffective C2 concentration of 125/250 ng/ml, a further more than twofold increase in surfactant secretion was noted. A significant amplifying effect of C2 toxin pretreatment on the stretch-elicited [3H]PC release was even noted for the very low toxin concentration of 50/100 ng/ml.
|
|
Secretagogue-induced Changes of the AET2 F- and G-Actin Ratio
All chemical secretagogues, ATP, phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), and terbutaline induced a reversible depolymerization of the epithelial F-actin, as evident in Figure 8. Nadir values of F-actin content were noted within 3 min (ATP) to 10 min (TPA, terbutaline) after secretagogue exposure, with minimum values ranging between 75 and 85% of baseline. Time course of restoration of basal F-actin levels ranged between approximately 30 min (ATP) and greater than or equal to 180 min (TPA, terbutaline).
|
Control Experiments
ADP ribosylation of a 43-kilodalton (kD) protein in AET2 was demonstrated to occur in a dose-dependent manner in response to C2 toxin. As evident from the autoradiogram in Figure 9, the higher the concentrations of components I and II to which the intact cells were exposed, the less effective was the post-labeling of lysed cells with [32P]NAD by component I. These results indicate dose dependency preceding ribosylation of the 43-kD protein with non-labeled ADP in intact epithelial cells exposed to C2 toxin.
|
In the concentration range used, C2 toxin incubation evoked only a very moderate, protracted LDH release as a marker of overt cell lysis. Within 60 min, 0.5-1% of total cellular LDH was liberated, both in controls and in AET2 exposed to the highest toxin concentration currently used, 375/750 ng/ml component I/II.
AET2 loaded with CFDA as a marker of vitality exhibited fluorochromasia within minutes and showed no decrase in fluorescence activity after application of C2 toxin in the highest concentration range used, 375/750 ng/ml component I/II.
| |
DISCUSSION |
|---|
|
|
|---|
C2 toxin exposure of AET2 was found to cause a dose-dependent decay of F-actin concomitant with G-actin accumulation in parallel with a marked amplification of the baseline surfactant secretory response. ADP ribosylation of nonmuscle G-actin, which blocks its contribution to polymerization, has been disclosed as the molecular C2 toxin mechanism in various cell types (12), and the currently performed control experiments with [32P]NAD labeling of a 43-kD protein demonstrate a corresponding efficacy of the clostridial toxin also in the cultured alveolar epithelial cells. As anticipated from this basic toxin effect in the C2-treated AET2, an impressive overall shift of the G- to F-actin ratio occurred with a reduction of the total cellular F-actin content to approximately 20% of baseline values at the highest C2I/II concentrations used. This decay of F-actin was closely linked with enhanced baseline surfactant secretion in AET2, and at toxin doses greater than or equal to 250/500 ng/ml, a more than twofold increase in baseline PC release was noted. The assumption that this enhancement of baseline surfactant secretion is directly related to the depolymerization of F-actin is based on: (1) the fact that C2 is a very specific tool targeting solely the actin system, as detailed above; and (2) the finding that pretreatment with another specific tool addressing the actin system, phalloidin, virtually completely reverses the C2 effect on baseline PC release. Phalloidin is known to bind highly specifically to actin filaments more tightly than to actin monomers, thereby decreasing the rate of actin depolymerization and shifting the equilibrium between G- and F-actin to the filament side (21, 23). The current in vitro findings thus correspond very nicely with the morphologic observations of enhanced lamellar body membrane fusion and exocytosis in intact rabbit lungs exposed to C2 toxin in the absence of any other stimulus application (14).
In addition to provoking enhanced baseline PC release, C2 toxin pre-exposure significantly augmented the surfactant secretory response of the alveolar epithelial cells to both soluble secretagogues and mechanical stretch. This amplification of the response pattern was particularly evident for the biophysical challenge, which provoked greater than twofold enhanced PC liberation in C2 pretreated as compared with non-pretreated cells. Interestingly, this marked efficacy was elicited by very low botulinum toxin concentrations (50/100 and 125/250 ng/ml), which did not affect the rate of baseline surfactant secretion. Moreover, at the dosage of 50/100 ng/ml C2, the overall cellular F-actin content was only marginally reduced by approximately 10%. These findings may suggest preferential C2 toxin effects on a distinct, functionally specific actin pool (see below) as an underlying mechanism of such marked amplification of the mechanical stretch-evoked secretory response. This notion is further supported by the observation that a rapid-onset, transient decrease of the overall AET2 F-actin content is a consistent part of the epithelial response pattern to all secretagogues investigated, with nadir values of approximately 15- 25% F-actin reduction below baseline. The kinetics of this transient change in actin assembly is compatible with the established time course of PC secretion in response to these secretagogues (1, 24, 25). It is tempting to speculate that a F- to G-actin shift is part of the stretch- and/or receptor-dependent surfactant secretory response of AET2 as schematically depicted in Figure 10.
|
The most likely explanation of the impressive impact of an altered state of actin assembly on the surfactant secretory process under both baseline conditions and in response to biochemical and biophysical stimuli is based on the notion that the cortical cytoplasm of the alveolar epithelial cells, the area ranging between the apical aspect of the plasma membrane and the lamellar bodies, is enriched in F-actin (5, 26). This subplasmalemmal actin filament system may represent a mechanical hindrance that has to be transiently depolymerized to allow lamellar body membrane fusion and exocytosis (27). In addition, the overall viscoelastic properties of the cytoplasm, also known to be largely dependent on the network of cross-linked actin filaments, may be operative in the limitation of lamellar body membrane fusion under baseline conditions. Moreover, changes in the state of actin assembly may be an integral part of signaling cascades provoked by biochemical and biophysical stimulation, as demonstrated for other cell types. The dependence of receptor kinetics (28), spatial and temporal limitation of ligand-evoked second messenger elevation (21), sensory and response elements involved in mechanotransduction (3, 29) and organization of plasma and nuclear ion channels (30) on the state of actin assembly may be relevant in this context. Further studies are clearly necessary to elucidate the role of actin in the regulation of epithelial surfactant secretion in more detail.
In conclusion, the current study demonstrates that the actin microfilament system plays a major role in the regulation of surfactant secretion in alveolar epithelial cells, occurring via exocytosis of preformed lamellar bodies. Depolymerization of actin was noted to be linked with enhanced secretion both under baseline conditions and in response to stimulation by mechanical stress and secretagogue exposure. Cytoskeletal control of compartmentalization and a role of actin in signaling cascades may be suggested as underlying events.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Prof. Werner Seeger, Medizinische Klinik II, Dept. of Internal Medicine, Klinikstrasse 36, D-35385 Giessen, Germany.
(Received in original form January 27, 1998 and in revised form June 11, 1998).
Acknowledgments: Supported by the Deutsche Forschungsgemeinschaft (SFB 547, project B7).
| |
References |
|---|
|
|
|---|
1.
Wirtz, H. R. W., and
L. G. Dobbs.
1990.
Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells.
Science
250:
1266-1269
2. Rooney, S. A., S. L. Young, and C. R. Mendelson. 1994. Molecular and cellular processing of lung surfactant. FASEB J. 8: 957-967 [Abstract].
3. Hutcheson, I. R., and T. M. Griffith. 1996. Mechanotransduction through the endothelial cytoskeleton: mediation of flow but not agonist induced EDRF release. Br. J. Pharmacol. 118: 720-726 [Medline].
4. Bendayan, M.. 1982. Ultrastructural localization of actin in muscle, epithelial and secretory cells by applying the protein A-gold immunocytochemical technique. Histochem. J. 15: 39-58 .
5. Wright, J. R., and L. G. Dobbs. 1991. Regulation of pulmonary surfactant secretion and clearance. Annu. Rev. Physiol. 53: 395-414 [Medline].
6. Tsilibary, E. C., and M. C. Williams. 1983. Actin and secretion of surfactant. J. Histochem. Cytochem. 31: 1289-1297 [Abstract].
7.
Liu, L.,
W. Mengshu,
A. B. Fisher, and
U. J. P. Zimmermann.
1996.
Involvement of annexin II of lamellar bodies from alveolar epithelial
type II cells.
Am. J. Physiol.
270:
L668-L676
8. Rice, W. R., K. C. Osterhoudt, and J. A. Whitsett. 1984. Effect of cytochalasins on surfactant release from alveolar type II cells. Biochim. Biophys. Acta 805: 12-18 [Medline].
9. Urbanik, E., and B. R. Ware. 1989. Actin filament capping and cleaving activity of cytochalasins B, D, E, and H. Arch. Biochem. Biophys. 269: 181-187 [Medline].
10. Walling, E. A., G. A. Kraft, and B. R. Ware. 1988. Effect of cytochalasin on actin assembly. Arch. Biochem. Biophys. 264: 321-332 [Medline].
11. Verschueren, H., I. van der Taelen, J. Dewit, J. de Braekeler, P. de Baetselier, K. Aktories, and I. Just. 1995. Effects of clostridium botulinum C2 toxin and cytochalasin D on in vitro invasiveness, motility and F-actin content of a murine T-lymphoma cell line. Eur. J. Cell. Biol. 66: 335-341 [Medline].
12.
Aktories, K., and
A. Wegner.
1989.
ADP ribosylation of actin by clostridial toxins.
J. Cell Biol.
109:
1385-1387
13.
Emert, L.,
H. Brückner,
D. Walmrath,
F. Grimminger,
K. Aktories,
N. Suttorp,
H. R. Duncker, and
W. Seeger.
1995.
Role of endothelial cytoskeleton in high-permeability edema due to botulinum C2 toxin in
perfused rabbit lungs.
Am. J. Physiol.
268:
L753-L761
14.
Emert, L.,
H. R. Duncker,
H. Brückner,
F. Grimminger,
T. Hansen,
R. Rössig,
K. Aktories, and
W. Seeger.
1997.
Ultrastructural changes of
lung capillary endothelium in response to botulinum C2 toxin.
J. Appl.
Physiol.
82:
382-388
15. Suttorp, N., M. Polley, J. Seibold, H. Schnittler, W. Seeger, F. Grimminger, and K. Aktories. 1991. Adenosine diphosphate-rybolisation of G-actin by botulinum C2 toxin increases endothelial permeability in vitro. J. Clin. Invest. 87: 1575-1584 .
16.
Atkinson, P. H..
1975.
Synthesis and assembly of HeLa cell plasma membrane glycoproteins and proteins.
J. Biol. Chem.
250:
2123-2134
17. Reuner, K. H., M. Wiederhold, P. Dunker, I. Just, R. M. Bohle, M. Kröger, and N. Katz. 1995. Autoregulation of actin synthesis in hepatocytes by transcriptional and posttranscriptional mechanisms. Eur. J. Biochem. 230: 32-37 [Medline].
18. Wysolmerski, R. B., and D. Lagunoff. 1988. Inhibition of endothelial cell retraction by ATP depletion. Am. J. Pathol. 132: 28-37 [Abstract].
19. Aktories, K., T. Ankenbauer, B. Schehring, and K. H. Jacobs. 1986. ADP-ribosylation of platelet actin by botulinum C2 toxin. Eur. J. Biochem. 161: 155-162 [Medline].
20. Lämmli, U. K.. 1970. Cleavage of structural proteins during the assembly of bacteriophages T4. Nature 227: 680-685 [Medline].
21. Grimminger, F., U. Sibelius, K. Aktories, N. Suttorp, and W. Seeger. 1991. Inhibition of cytoskeletal rearrangement by botulinum C toxin amplifies ligand-evoked lipid mediator generation in human neutrophils. Mol. Pharmacol. 40: 563-571 [Abstract].
22.
Cooper, J. A..
1987.
Effects of cytochalasin and phalloidin on actin.
J.
Cell Biol.
105:
1473-1478
23.
Mathews, J. B.,
J. A. Smith, and
B. J. Hrnjez.
1997.
Effects of F-actin stabilization or disassembly on epithelial C1 secretion and Na-K-2C1
cotransport.
Am. J. Physiol.
272:
C254-C262
24.
Brown, L. A. S.,
S. M. Pasquale, and
W. J. Longmore.
1985.
Role of microtubules in surfactant secretion.
J. Appl. Physiol.
58:
1866-1873
25. Rooney, S. A., and L. I. Gobran. 1997. Influence of the protein kinase C inhibitor 3-[1-[3-(amidinothio) propyl]-1H-indoyl-3-yl]-3-(1-methyl-1H-indoyl-3-yl) maleimide methane sulfonate (Ro-318220) on surfactant secretion in type II pneumocytes. Biochem. Pharmacol. 53: 597-601 [Medline].
26. Durrbach, A., D. Louvard, and E. Coudrier. 1996. Actin filaments facilitate two steps of endocytosis. J. Cell Sci. 109: 457-465 [Abstract].
27. Kliewer, M., E. K. Fram, A. R. Brody, and S. L. Young. 1985. Secretion of surfactant by rat alveolar type II cells: morphometric analysis and three-dimensional reconstruction. Exp. Lung Res. 9: 351-361 [Medline].
28.
Norgauer, J.,
I. Just,
K. Aktorius, and
L. A. Sklar.
1989.
Influence of botulinum C2 toxin on F-actin and N-formyl peptide receptor dynamics
in human neutrophils.
J. Cell Biol.
109:
1133-1140
29. Glogauer, M., P. Arora, G. Yao, I. Sokholov, J. Ferrier, and C. A. G. McCulloch. 1997. Calcium ions and tyrosine phosphorylation interact coordinately with actin to regulate cytoprotective responses to stretching. J. Cell Sci. 110: 11-21 [Abstract].
30.
Ismalov, I. I.,
B. K. Berdiev,
V. G. Shlyonsky,
C. M. Fuller,
A. G. Prat,
B. Jovov,
H. F. Cantiello,
D. A. Ausiello, and
D. J. Benos.
1997.
Role
of actin in regulation of epithelial sodium channels by CFTR.
Am. J. Physiol.
272:
C1077-C1086
This article has been cited by other articles:
![]() |
A. V. Andreeva, M. A. Kutuzov, and T. A. Voyno-Yasenetskaya Regulation of surfactant secretion in alveolar type II cells Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L259 - L271. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wissel, C. Schulz, M. Rudiger, M. Krull, P. A. Stevens, and R. R. Wauer Chlamydia pneumoniae Affect Surfactant Trafficking and Secretion Due to Changes of Type II Cell Cytoskeleton Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 303 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Burgoyne and A. Morgan Secretory Granule Exocytosis Physiol Rev, April 1, 2003; 83(2): 581 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Singer, M. Frick, T. Haller, S. Bernet, M. Ritsch-Marte, and P. Dietl Mechanical Forces Impeding Exocytotic Surfactant Release Revealed by Optical Tweezers Biophys. J., February 1, 2003; 84(2): 1344 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Haller, P. Dietl, K. Pfaller, M. Frick, N. Mair, M. Paulmichl, M. W. Hess, J. Furst, and K. Maly Fusion pore expansion is a slow, discontinuous, and Ca2+-dependent process regulating secretion from alveolar type II cells J. Cell Biol., October 15, 2001; 155(2): 279 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dietl, T. Haller, N. Mair, and M. Frick Mechanisms of Surfactant Exocytosis in Alveolar Type II Cells In Vitro and In Vivo Physiology, October 1, 2001; 16(5): 239 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Frick, S. Eschertzhuber, T. Haller, N. Mair, and P. Dietl Secretion in Alveolar Type II Cells at the Interface of Constitutive and Regulated Exocytosis Am. J. Respir. Cell Mol. Biol., September 1, 2001; 25(3): 306 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Berrios, M. A. Schroeder, and R. D. Hubmayr Mechanical properties of alveolar epithelial cells in culture J Appl Physiol, July 1, 2001; 91(1): 65 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Isowa and M. Liu Role of LPS-induced microfilament depolymerization in MIP-2 production from rat pneumocytes Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L762 - L770. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liu and M. Post Cellular Responses to Mechanical Stress: Invited Review: Mechanochemical signal transduction in the fetal lung J Appl Physiol, November 1, 2000; 89(5): 2078 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Klussmann, G. Tamma, D. Lorenz, B. Wiesner, K. Maric, F. Hofmann, K. Aktories, G. Valenti, and W. Rosenthal An Inhibitory Role of Rho in the Vasopressin-mediated Translocation of Aquaporin-2 into Cell Membranes of Renal Principal Cells J. Biol. Chem., June 1, 2001; 276(23): 20451 - 20457. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Haller, P. Dietl, K. Pfaller, M. Frick, N. Mair, M. Paulmichl, M. W. Hess, J. Furst, and K. Maly Fusion pore expansion is a slow, discontinuous, and Ca2+-dependent process regulating secretion from alveolar type II cells J. Cell Biol., October 15, 2001; 155(2): 279 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tamma, E. Klussmann, K. Maric, K. Aktories, M. Svelto, W. Rosenthal, and G. Valenti Rho inhibits cAMP-induced translocation of aquaporin-2 into the apical membrane of renal cells Am J Physiol Renal Physiol, December 1, 2001; 281(6): F1092 - F1101. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |